法瓦丹塔的药理应用:专利审查
Willams Alves da Silva1, Igor Lima Soares1, Kristiana Cerqueira Mousinho2
1Graduate Program in Technological Development and Innovation in Medicines (DITM), Federal University of Ceará (UFC), Fortaleza, Brazil.
Recent patents on biotechnology
|April 11, 2025
概括
富含奎尔塞丁和鲁丁的Fava d'anta具有显著的制药潜力. 专利分析揭示了全球创新,突出了其在新药和化品的抗氧化和抗炎应用中的应用.
科学领域:
- 植物化学 植物化学
- 药理学 药理学是指药理学的学科.
- 知识产权分析知识产权分析
背景情况:
- 药用植物对于低收入国家的医疗保健至关重要.
- 法瓦丹塔 (Dimorphandra spp.) 是一种植物. 是一个关键的巴西植物,含有生物活性化合物,如奎尔丁和鲁丁.
- 药用植物的可持续利用面临着诸如过度采摘等挑战,需要管理和生物技术解决方案.
研究的目的:
- 审查Fava d'anta的专利及其相关的药理学申请.
- 为了确定Fava d'anta衍生产品的全球创新趋势.
- 评估Fava d'anta在开发新药,营养药和化品方面的潜力.
主要方法:
- 在四个数据库中进行全面的专利搜索:USPTO,WIPO,Espacenet和INPI.
- 收集和选文件以确定相关专利.
- 分析专利数据以确定创新度和应用领域.
主要成果:
- 最初确定了109项专利,其中26项符合纳入标准.
- 在Fava d'anta技术的创新集中在欧洲和美国.
- 法瓦丹塔表现出抗氧化和抗炎性质,归因于多,在营养品和化品中具有应用.
结论:
- 专利数据证实了Dimorphandra物种对于植物产品的显著潜力,特别是由于Quercetin和Rutin.
- 需要进一步的研究来阐明Fava d'anta生物活性化合物的作用机制.
- 增强的技术应用,特别是在化品行业,需要进一步研究.
关键词:
迪莫夫兰德拉 (Dimorphandra) 是一个有形的.创新 创新 创新 创新 创新 创新知识产权知识产权是知识产权.专利指标. 专利指标.这些都是专利,专利.这是一个常规的,常规的,常规的.更多相关视频
09:16Author Spotlight: Optimization of Processing Technology for Tiebangchui with Zanba Based on CRITIC Combined with Box-Behnken Response Surface Method
Published on: May 12, 2023
1.0K
09:34Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
8.9K
相关概念视频
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
329
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
329
01:26Cholinergic Antagonists: Therapeutic Uses
681
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
681
01:19Pharmacovigilance
753
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
753
01:11Clinical Trials: Overview
2.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.5K
01:28Structure-Activity Relationships and Drug Design
461
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
461